Literature DB >> 1999225

Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors.

M Stein1, S Gordon.   

Abstract

In spite of the physiologic and pathologic importance of tumor necrosis factor (TNF), the cellular factors that govern its release by macrophages (M phi) are poorly understood, in comparison with other secretory products. We have studied the role of M phi heterogeneity and of plasma membrane receptors in regulating TNF release in vitro. Resident and various exudate murine peritoneal M phi populations were challenged with lipopolysaccharide (LPS) or different phagocytic particles, and TNF release assayed by cytotoxicity for L-929 fibroblasts. Resident peritoneal M phi (RPM phi) released a small amount of TNF in response to LPS whereas thioglycollate-elicited M phi (TPM phi) released high levels of TNF (5000 U/3 x 10(5) M phi/ml). M phi elicited by Bio-Gel polyacrylamide beads (BgPM phi), another nonspecific inflammatory stimulus, or early in the course of intraperitoneal Bacillus Calmette-Guérin infection, before recruited cells become immunologically activated, released tenfold less TNF after the same stimulus. By contrast, TNF release in response to various phagocytic triggers was similar (approximately 300-600 U/3 x 10(5) M phi/ml) in all M phi populations including RPM phi. The response by BgPM phi to LPS was enhanced by pre-treatment in vitro with interferon-gamma or thioglycollate broth. With respect to phagocytic receptor triggering we found that complement receptor type 3 (CR3) ligation or latex uptake did not mediate release of significant quantities of TNF (less than 48 U/3 x 10(5) M phi/ml) by any M phi, whereas ligation of the Fc receptor for IgG1/IgG2b subclasses or of receptors for zymosan particles sufficed, in the absence of ingestion, to induce release of circa 500 U/3 x 10(5) M phi/ml TNF by all M phi tested. Our studies show that M phi vary in respect to priming for TNF release and that heterogeneity should be related to a particular triggering stimulus. Furthermore, the capacity of some M phi populations to release unusually high levels of TNF depends on immune or nonspecific stimuli subsequent to the process of inflammatory recruitment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999225     DOI: 10.1002/eji.1830210227

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways.

Authors:  Heather S Smallwood; Daniel López-Ferrer; Thomas C Squier
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

2.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-alpha and IL-6 in macrophages.

Authors:  J Marcinkiewicz; B Czajkowska; A Grabowska; A Kasprowicz; B Kociszewska
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

4.  Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages.

Authors:  H Tapper; R Sundler
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

5.  Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages.

Authors:  M G Bradbury; C Moreno
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 6.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

7.  In Vivo Cellular Imaging for Translational Medical Research.

Authors:  Ali S Arbab; Branislava Janic; Jodi Haller; Edyta Pawelczyk; Wei Liu; Joseph A Frank
Journal:  Curr Med Imaging Rev       Date:  2009-02-01

8.  A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.

Authors:  Deborah D Crane; Shayna L Warner; Catharine M Bosio
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Recombinant BCG therapy suppresses melanoma tumor growth.

Authors:  R B Duda; H Yang; D D Dooley; G Abu-Jawdeh
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

10.  Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination.

Authors:  Allison M Dyevoich; Karen M Haas
Journal:  Mol Cancer Ther       Date:  2020-03-18       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.